Apogee Therapeutics, Inc. (APGE) Soars on Promising Phase 2 Results for Atopic Dermatitis Drug
Apogee Therapeutics, Inc.
Apogee Therapeutics Inc. (APGE)
Market is closed
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $49.85 | 12,500 | $623,125.00 | 20,000 | 2024-12-12 | Filing | |
| $49.02 | 7,500 | $367,650.00 | 7,500 | 2024-12-12 | Filing | |
| $17.00 | 1,750,000 | $29,750,000.00 | 1,750,000 | 2023-07-13 | Filing | |
| $17.00 | 892,529 | $15,172,993.00 | 892,529 | 2023-07-13 | Filing | |
| $17.00 | 1,992,734 | $33,876,478.00 | 1,992,734 | 2023-07-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $37.78 | 2,725 | $102,950.50 | 236,273 | 2025-08-06 | Filing | |
| $46.26 | 746 | $34,509.96 | 238,998 | 2025-07-02 | Filing | |
| $45.49 | 2,935 | $133,513.15 | 239,744 | 2025-07-02 | Filing | |
| $44.77 | 6,409 | $286,930.93 | 242,679 | 2025-07-02 | Filing | |
| $36.96 | 2,725 | $100,716.00 | 241,723 | 2025-06-04 | Filing |
News See All
11 Best Future Stocks to Buy Now
Over the past year, investors have poured money into cutting-edge technologies like artificial intelligence and electric cars.
12 Oversold NASDAQ Stocks to Buy Now
On July 14, Max Kettner, chief multi-asset strategist at HSBC, appeared on CNBC to talk about the global markets amid trade tensions.
Canaccord Genuity Reiterated a Buy Rating on Apogee Therapeutics (APGE)
Apogee Therapeutics, Inc. (NASDAQ:APGE) is one of the 11 Hot New Stocks to Invest in Now. On July 7, analyst Edward Nash of Canaccord Genuity reiterated a Buy rating on Apogee Therapeutics, Inc.
11 Hot New Stocks to Invest in Now
On June 12, Reuters reported that the US IPO market has come to life after a sharp decline since Liberation Day.
Apogee Therapeutics (APGE) Falls 17%, Positive Trial Results Fail to Impress Investors
Apogee Therapeutics fell by 17.32 percent on Monday to end at $39.24 apiece as investors disposed of positions amid the broader market pessimism, shunning positive results from the company’s clinical...
Apogee Therapeutics Shares Positive Interim Phase 1b Results for APG808 in Asthma
Apogee Therapeutics Inc. (NASDAQ:APGE) is one of the best hot stocks to buy according to Wall Street analysts.
11 Best Hot Stocks to Buy According to Wall Street Analysts
On July 1, Ralph Schlosstein, Evercore's chairman emeritus and BlackRock's co-founder, joined 'Closing Bell Overtime' on CNBC to talk about his outlook for markets heading into the second half of the ...
12 Best IPO Stocks to Buy in 2025
On February 25, Hamilton Lane co-CEO Erik Hirsch joined 'Closing Bell Overtime' on CNBC to discuss the developments that currently hinder the IPO pipeline.
10 Best Small-Cap Stocks to Buy Now
The S&P 500 index has reached its all-time highs, achieving returns of over 20% for two second consecutive years post-COVID.
Billionaire Hedge Funds
